Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, Weinberg JM, Kircik L, Han G, Langley RG, Neimann AL, Lebwohl M. Burshtein J, et al. Among authors: golant ak. J Drugs Dermatol. 2024 Aug 1;23(8):592-599. doi: 10.36849/JDD.8246. J Drugs Dermatol. 2024. PMID: 39093660 Review.
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement.
Butler DC, Simpson E, Guttman-Yassky E, Eichenfield LF, Golant AK, Koo JYM, Armstrong AW, Alexis AF, Lio PA, Marson JW, Lebwohl M. Butler DC, et al. Among authors: golant ak. J Dermatolog Treat. 2022 Jun;33(4):2397-2399. doi: 10.1080/09546634.2021.1966356. Epub 2021 Aug 16. J Dermatolog Treat. 2022. PMID: 34365875 Free article. No abstract available.
Psoriasis and the metabolic syndrome.
Alsufyani MA, Golant AK, Lebwohl M. Alsufyani MA, et al. Among authors: golant ak. Dermatol Ther. 2010 Mar-Apr;23(2):137-43. doi: 10.1111/j.1529-8019.2010.01307.x. Dermatol Ther. 2010. PMID: 20415820
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.
Ungar B, Glickman JW, Golant AK, Dubin C, Marushchak O, Gontzes A, Mikhaylov D, Singer GK, Baum D, Wei N, Sanin A, Gruenstein D, Lebwohl MG, Pavel AB, Guttman-Yassky E. Ungar B, et al. Among authors: golant ak. J Allergy Clin Immunol Pract. 2022 Jan;10(1):134-142. doi: 10.1016/j.jaip.2021.10.050. Epub 2021 Nov 1. J Allergy Clin Immunol Pract. 2022. PMID: 34737108 Free PMC article.
Dermatologic findings in 2 patients with COVID-19.
Rivera-Oyola R, Koschitzky M, Printy R, Liu S, Stanger R, Golant AK, Lebwohl M. Rivera-Oyola R, et al. Among authors: golant ak. JAAD Case Rep. 2020 Apr 28;6(6):537-539. doi: 10.1016/j.jdcr.2020.04.027. eCollection 2020 Jun. JAAD Case Rep. 2020. PMID: 32346588 Free PMC article. No abstract available.
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.
Ungar B, Lavin L, Golant AK, Gontzes A, David E, Estrada YD, Singer GK, Pavel AB, Guttman-Yassky E. Ungar B, et al. Among authors: golant ak. Ann Allergy Asthma Immunol. 2022 Jun;128(6):734-736. doi: 10.1016/j.anai.2022.03.019. Epub 2022 Mar 26. Ann Allergy Asthma Immunol. 2022. PMID: 35346880 Free PMC article. No abstract available.
11 results